Sonoma Pharmaceuticals (SNOA) Change in Inventory (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Change in Inventory of -$19000.0 for Q1 2026, up 93.47% year-over-year from -$9820.6 in Q1 2025, and down 147.5% quarter-over-quarter from $40000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Change in Inventory (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Change in Inventory history runs 17 years deep, the most recent figure standing at -$19000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 93.47% year-over-year to -$19000.0; the TTM figure through Mar 2026 stood at $465000.0 (up 19.85% YoY), while the FY2026 annual figure was $465000.0, up 19.85% from the prior year.
- Change in Inventory for Q1 2026 stood at -$19000.0, down from $40000.0 in the prior quarter.
- The five-year high for Change in Inventory was $652000.0 in Q2 2025, with the low at -$291000.0 in Q1 2025.
- The 5-year median for Change in Inventory is -$19000.0 (2026), against an average of $23705.9.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory jumped 1844.44% in 2022, then slumped 231.43% in 2023.
- Sonoma Pharmaceuticals' Change in Inventory stood at -$285000.0 in 2022, then surged by 274.04% to $496000.0 in 2023, then slumped by 37.7% to $309000.0 in 2024, then slumped by 87.06% to $40000.0 in 2025, then slumped by 147.5% to -$19000.0 in 2026.
- Business Quant data shows SNOA's Change in Inventory at -$19000.0 in Q1 2026, $40000.0 in Q4 2025, and -$208000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | 81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81,000.00 |
| Jun 30, 2026 | 81,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Jun 30, 2025 | 652,000.00 |
| Jun 30, 2025 | 652,000.00 |
| Mar 31, 2025 | -291,000.00 |
| Mar 31, 2025 | -291,000.00 |
| Dec 31, 2024 | 309,000.00 |
| Dec 31, 2024 | 309,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | -277,000.00 |
| Mar 31, 2024 | -277,000.00 |